Head to head
Agilent Technologies vs Thermo Fisher Scientific
Side-by-side on the measures that matter, with a plain-English read. Full detail: A · TMO
A
Agilent Technologies
175.96+1.67%
1-year price shape — +20% over the period
Quant Rating C · 61/100
vs
TMO
Thermo Fisher Scientific
684.89+1.64%
1-year price shape — +20% over the period
Quant Rating C · 61/100
1-year performance, rebased to 100
Thermo Fisher Scientific edges it on the scoreable measures. Thermo Fisher Scientific has done best over the past year (+20%); Thermo Fisher Scientific earns the most per share.
| A | TMO | |
|---|---|---|
| Snapshot | ||
| Sector | -- | -- |
| Last price | 175.96 | 684.89 |
| Change today | +1.67% | +1.64% |
| 1-year return | +19.6% | +20.0% |
| Market cap | $49.61B | $253.24B |
| 52-week range | 107.98 – 179.10 | 434.50 – 705.79 |
| Valuation | ||
| P/E (TTM) | 34.71 | 36.12 |
| P/E percentile, own 5-yr range | 83rd | 91st |
| P/B | 6.74 | 4.62 |
| Dividend yield | 0.58% | 0.27% |
| Profitability & growth | ||
| EPS (TTM) | 4.57 | 17.74 |
| Net profit (TTM) | $1.29B | $6.56B |
| Revenue (TTM) | $7.37B | $46.34B |
| Revenue growth (YoY) | +8.1% | +10.5% |
| Gross margin | 53.8% | 40.8% |
| Operating margin | 22.2% | 18.3% |
| Net margin | 19.5% | 15.0% |
| Free cash flow (TTM) | $1.27B | $7.32B |
| Ownership & sentiment | ||
| Institutional ownership | 94.0% | 92.6% |
| Insider activity (12mo) | 17 buy / 28 sell | 22 buy / 28 sell |
| Short interest (% of float) | 1.9% | 1.5% |
| Analyst consensus | 85% buy / 15% hold (13) | 88% buy / 12% hold (16) |
| Analyst price target | $186 (+6%) | $749 (+9%) |
| StockVane view | ||
| StockVane Quant Rating | C (61) | C (61) |
| Company | ||
| Employees | 18,100 | 125,000 |
| Founded | 1999 | 1956 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.